• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于生物导向合成的甲亚胺叶立德的催化对映选择性1,3-偶极环加成反应

Catalytic enantioselective 1,3-dipolar cycloadditions of azomethine ylides for biology-oriented synthesis.

作者信息

Narayan Rishikesh, Potowski Marco, Jia Zhi-Jun, Antonchick Andrey P, Waldmann Herbert

机构信息

Max-Planck Institut für Molekulare Physiologie , Abteilung Chemische Biologie, Dortmund 44227, Germany.

出版信息

Acc Chem Res. 2014 Apr 15;47(4):1296-310. doi: 10.1021/ar400286b. Epub 2014 Mar 22.

DOI:10.1021/ar400286b
PMID:24730692
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4004623/
Abstract

Cycloaddition reactions are among the most powerful methods for the synthesis of complex compounds. In particular, the development and application of the 1,3-dipolar cycloaddition, an important member of this reaction class, has grown immensely due to its powerful ability to efficiently build various five-membered heterocycles. Azomethine ylides are commonly used as dipoles for the synthesis of the pyrrolidine scaffold, which is an important motif in natural products, pharmaceuticals, and biological probes. The reaction between azomethine ylides and cyclic dipolarophiles allows access to polycyclic products with considerable complexity. The extensive application of the 1,3-dipolar cycloaddition is based on the fact that the desired products can be obtained with high yield in a regio- and stereocontrolled manner. The most attractive feature of the 1,3-dipolar cycloaddition of azomethine ylides is the possibility to generate pyrrolidines with multiple stereocenters in a single step. The development of enantioselective cycloadditions became a subject of intensive and impressive studies in recent years. Among many modes of stereoinduction, the application of chiral metal-ligand complexes has emerged as the most viable option for control of enantioselectivity. In chemical biology research based on the principle of biology-oriented synthesis (BIOS), compound collections are prepared inspired by natural product scaffolds. In BIOS, biological relevance is employed as the key criterion to generate hypotheses for the design and synthesis of focused compound libraries. In particular, the underlying scaffolds of natural product classes provide inspiration for BIOS because they define the areas of chemical space explored by nature, and therefore, they can be regarded as "privileged". The scaffolds of natural products are frequently complex and rich in stereocenters, which necessitates the development of efficient enantioselective methodologies. This Account highlights examples, mostly from our work, of the application of 1,3-dipolar cycloaddition reactions of azomethine ylides for the catalytic enantioselective synthesis of complex products. We successfully applied the 1,3-dipolar cycloaddition in the synthesis of spiro-compounds such as spirooxindoles, for kinetic resolution of racemic compounds in the synthesis of an iridoid inspired compound collection and in the synthesis of a nitrogen-bridged bicyclic tropane scaffold by application of 1,3-fused azomethine ylides. Furthermore, we performed the synthesis of complex molecules with eight stereocenters using tandem cycloadditions. In a programmable sequential double cycloaddition, we demonstrated the synthesis of both enantiomers of complex products by simple changes in the order of addition of chemicals. Complex products were obtained using enantioselective higher order [6 + 3] cycloaddition of azomethine ylides with fulvenes followed by Diels-Alder reaction. The bioactivity of these compound collections is also discussed.

摘要

环加成反应是合成复杂化合物最有效的方法之一。特别是1,3 - 偶极环加成反应作为这类反应的一个重要成员,由于其能够高效构建各种五元杂环的强大能力,其发展和应用得到了极大的拓展。甲亚胺叶立德通常用作合成吡咯烷骨架的偶极体,吡咯烷骨架是天然产物、药物和生物探针中的一个重要结构单元。甲亚胺叶立德与环状亲偶极体之间的反应能够得到具有相当复杂性的多环产物。1,3 - 偶极环加成反应的广泛应用基于这样一个事实,即可以通过区域和立体控制的方式高产率地获得所需产物。甲亚胺叶立德的1,3 - 偶极环加成反应最吸引人的特点是能够在一步反应中生成具有多个立体中心的吡咯烷。近年来,对映选择性环加成反应的发展成为了深入且引人注目的研究课题。在众多立体诱导模式中,手性金属 - 配体配合物的应用已成为控制对映选择性最可行的选择。在基于生物导向合成(BIOS)原理的化学生物学研究中,化合物库是受天然产物骨架启发而制备的。在BIOS中,生物学相关性被用作生成聚焦化合物库设计和合成假设的关键标准。特别是天然产物类别的潜在骨架为BIOS提供了灵感,因为它们定义了自然界探索的化学空间区域,因此可以被视为“特权”骨架。天然产物的骨架通常复杂且富含立体中心,这就需要开发高效的对映选择性方法。本综述重点介绍了甲亚胺叶立德的1,3 - 偶极环加成反应在催化对映选择性合成复杂产物中的应用实例,这些实例大多来自我们的工作。我们成功地将1,3 - 偶极环加成反应应用于螺环化合物(如螺环氧化吲哚)的合成、在合成环烯醚萜类化合物库时对外消旋化合物的动力学拆分以及通过应用1,3 - 稠合甲亚胺叶立德合成氮桥双环托烷骨架。此外,我们还通过串联环加成反应合成了具有八个立体中心的复杂分子。在一个可编程的顺序双环加成反应中,我们通过简单改变化学物质添加顺序证明了合成复杂产物的两种对映体。通过甲亚胺叶立德与富烯的对映选择性高阶[6 + 3]环加成反应,随后进行狄尔斯 - 阿尔德反应,得到了复杂产物。本文还讨论了这些化合物库的生物活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/e742b2650d66/ar-2013-00286b_0030.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/cae2ccebb230/ar-2013-00286b_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/aa485fd4af1f/ar-2013-00286b_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/e4f11e93d393/ar-2013-00286b_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/46d3c8721e75/ar-2013-00286b_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/2e10285ddbdb/ar-2013-00286b_0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/195ebfb37ede/ar-2013-00286b_0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/80d687db4930/ar-2013-00286b_0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/018acade9034/ar-2013-00286b_0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/71d7f179f004/ar-2013-00286b_0014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/b6d07aa30f39/ar-2013-00286b_0015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/b7d7be94972e/ar-2013-00286b_0016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/33959f20df26/ar-2013-00286b_0017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/f8ca02b2ea93/ar-2013-00286b_0018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/7c791049c32e/ar-2013-00286b_0019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/6b071d61ac8d/ar-2013-00286b_0020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/a7ff5b553705/ar-2013-00286b_0021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/e8bc371d340a/ar-2013-00286b_0022.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/75996f26db2a/ar-2013-00286b_0023.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/dd3aa3256626/ar-2013-00286b_0024.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/cfcf7672b894/ar-2013-00286b_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/250935395895/ar-2013-00286b_0025.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/9b53a75eb527/ar-2013-00286b_0026.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/514432800d5b/ar-2013-00286b_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/a0bc28dc52ac/ar-2013-00286b_0027.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/27d85e4c22a4/ar-2013-00286b_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/cdd26f489bf4/ar-2013-00286b_0028.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/3d699a59beb6/ar-2013-00286b_0029.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/dc3b4eda6799/ar-2013-00286b_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/e742b2650d66/ar-2013-00286b_0030.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/cae2ccebb230/ar-2013-00286b_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/aa485fd4af1f/ar-2013-00286b_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/e4f11e93d393/ar-2013-00286b_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/46d3c8721e75/ar-2013-00286b_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/2e10285ddbdb/ar-2013-00286b_0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/195ebfb37ede/ar-2013-00286b_0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/80d687db4930/ar-2013-00286b_0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/018acade9034/ar-2013-00286b_0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/71d7f179f004/ar-2013-00286b_0014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/b6d07aa30f39/ar-2013-00286b_0015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/b7d7be94972e/ar-2013-00286b_0016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/33959f20df26/ar-2013-00286b_0017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/f8ca02b2ea93/ar-2013-00286b_0018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/7c791049c32e/ar-2013-00286b_0019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/6b071d61ac8d/ar-2013-00286b_0020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/a7ff5b553705/ar-2013-00286b_0021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/e8bc371d340a/ar-2013-00286b_0022.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/75996f26db2a/ar-2013-00286b_0023.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/dd3aa3256626/ar-2013-00286b_0024.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/cfcf7672b894/ar-2013-00286b_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/250935395895/ar-2013-00286b_0025.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/9b53a75eb527/ar-2013-00286b_0026.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/514432800d5b/ar-2013-00286b_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/a0bc28dc52ac/ar-2013-00286b_0027.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/27d85e4c22a4/ar-2013-00286b_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/cdd26f489bf4/ar-2013-00286b_0028.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/3d699a59beb6/ar-2013-00286b_0029.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/dc3b4eda6799/ar-2013-00286b_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ac/4004623/e742b2650d66/ar-2013-00286b_0030.jpg

相似文献

1
Catalytic enantioselective 1,3-dipolar cycloadditions of azomethine ylides for biology-oriented synthesis.用于生物导向合成的甲亚胺叶立德的催化对映选择性1,3-偶极环加成反应
Acc Chem Res. 2014 Apr 15;47(4):1296-310. doi: 10.1021/ar400286b. Epub 2014 Mar 22.
2
Catalytic Asymmetric Reactions with -Metallated Azomethine Ylides.手性催化不对称反应与 -金属化亚胺叶立德。
Acc Chem Res. 2020 May 19;53(5):1084-1100. doi: 10.1021/acs.accounts.0c00113. Epub 2020 Apr 22.
3
1,3-Dipolar Cycloaddition Reactions of Azomethine Ylides with Carbonyl Dipolarophiles Yielding Oxazolidine Derivatives.甲亚胺叶立德与羰基亲偶极体的1,3-偶极环加成反应生成恶唑烷衍生物。
Molecules. 2016 Jul 23;21(8):935. doi: 10.3390/molecules21080935.
4
exo-Selective construction of spiro-[butyrolactone-pyrrolidine] via 1,3-dipolar cycloaddition of azomethine ylides with α-methylene-γ-butyrolactone catalyzed by Cu(I)/DTBM-BIPHEP.通过 Cu(I)/DTBM-BIPHEP 催化亚胺叶立德与 α-亚甲基-γ-丁内酯的 1,3-偶极环加成反应,高立体选择性地构建螺-[丁内酯-吡咯烷]。
Chem Commun (Camb). 2013 Oct 25;49(83):9642-4. doi: 10.1039/c3cc45493b.
5
Synthesis of benzosuberone-tethered spirooxindoles: 1-3-dipolar cycloaddition of azomethine ylides and arylidene benzosuberones.苯并环丁酮稠合螺环吲哚的合成:亚胺叶立德和芳基亚苄基苯并环丁酮的 1,3-偶极环加成反应。
Mol Divers. 2019 Aug;23(3):669-680. doi: 10.1007/s11030-018-9901-9. Epub 2018 Dec 10.
6
Regio- and Stereoselective Synthesis of Spiropyrrolizidines and Piperazines through Azomethine Ylide Cycloaddition Reaction.通过甲亚胺叶立德环加成反应实现螺吡咯烷和哌嗪的区域和立体选择性合成。
J Org Chem. 2015 Sep 18;80(18):9064-75. doi: 10.1021/acs.joc.5b01399. Epub 2015 Aug 31.
7
Catalytic enantioselective intramolecular 1,3-dipolar cycloaddition of azomethine ylides with fluorinated dipolarophiles.甲亚胺叶立德与氟化亲偶极体的催化对映选择性分子内1,3-偶极环加成反应
Chem Commun (Camb). 2022 Jul 12;58(56):7805-7808. doi: 10.1039/d2cc02902b.
8
1,3-Dipolar cycloaddition reactions of azomethine ylides with a cellulose-derived chiral enone. A novel route for organocatalysts development.氮宾与纤维素衍生的手性烯酮的 1,3-偶极环加成反应。手性有机催化剂发展的新途径。
Org Lett. 2012 May 18;14(10):2556-9. doi: 10.1021/ol3008588. Epub 2012 Apr 30.
9
Catalytic asymmetric construction of quaternary α-amino acid containing pyrrolidines through 1,3-dipolar cycloaddition of azomethine ylides to α-aminoacrylates.通过亚胺叶立德与α-氨基酸丙烯酰胺的 1,3-偶极环加成反应,催化不对称构建含季碳α-氨基酸的吡咯烷。
Chemistry. 2013 May 17;19(21):6739-45. doi: 10.1002/chem.201300204. Epub 2013 Mar 28.
10
Highly enantioselective asymmetric 1,3-dipolar cycloaddition of azomethine ylide catalyzed by a copper(I)/ClickFerrophos complex.铜(I)/ClickFerrophos络合物催化的甲亚胺叶立德的高度对映选择性不对称1,3-偶极环加成反应。
Org Lett. 2008 May 1;10(9):1747-50. doi: 10.1021/ol8003996. Epub 2008 Mar 29.

引用本文的文献

1
Untargeted Diversity-Oriented Synthesis for the Discovery of New Antitumor Agents: An Integrated Approach of Inverse Virtual Screening, Bioinformatics, and Omics for Target Deconvolution.用于发现新型抗肿瘤药物的非靶向多样性导向合成:一种用于靶点反卷积的逆虚拟筛选、生物信息学和组学的综合方法。
J Med Chem. 2025 Aug 14;68(15):16483-16517. doi: 10.1021/acs.jmedchem.5c01344. Epub 2025 Jul 24.
2
Unifying principles for the design and evaluation of natural product-inspired compound collections.天然产物启发型化合物库设计与评估的统一原则。
Chem Sci. 2025 Jan 24;16(7):2961-2979. doi: 10.1039/d4sc08017c. eCollection 2025 Feb 12.
3

本文引用的文献

1
Catalytic enantioselective synthesis of functionalized tropanes reveals novel inhibitors of hedgehog signaling.催化对映选择性合成官能化托品揭示了 hedgehog 信号的新型抑制剂。
Angew Chem Int Ed Engl. 2013 Dec 2;52(49):12892-6. doi: 10.1002/anie.201307392. Epub 2013 Oct 21.
2
Catalytic asymmetric 1,3-dipolar cycloaddition of two different ylides: facile access to chiral 1,2,4-triazinane frameworks.两种不同叶立德的催化不对称 1,3-偶极环加成反应:手性 1,2,4-三嗪烷骨架的简便合成方法。
Angew Chem Int Ed Engl. 2013 Nov 18;52(47):12377-80. doi: 10.1002/anie.201306300. Epub 2013 Oct 2.
3
Discovery of inhibitors of the Wnt and Hedgehog signaling pathways through the catalytic enantioselective synthesis of an iridoid-inspired compound collection.
Study of Cytotoxicity of Spiro-Fused [3-Azabicyclo[3.1.0]hexane]oxindoles and Cyclopropa[a]pyrrolizidine-oxindoles Against Tumor Cell Lines.
螺稠合[3-氮杂双环[3.1.0]己烷]氧化吲哚和环丙烷[a]吡咯里西啶-氧化吲哚对肿瘤细胞系的细胞毒性研究
Pharmaceuticals (Basel). 2024 Nov 25;17(12):1582. doi: 10.3390/ph17121582.
4
Utilizing MEDT analysis of [3 + 2] cycloaddition reaction: x-ray crystallography of spirooxindole linked with thiophene/furan heterocycles and triazole framework.利用[3+2]环加成反应的MEDT分析:与噻吩/呋喃杂环和三唑骨架相连的螺环氧化吲哚的X射线晶体学。
BMC Chem. 2024 Nov 14;18(1):229. doi: 10.1186/s13065-024-01343-8.
5
Synergistic Homogeneous Asymmetric Cu Catalysis with Pd Nanoparticle Catalysis in Stereoselective Coupling of Alkynes with Aldimine Esters.钯纳米颗粒催化与协同均相不对称铜催化在炔烃与醛亚胺酯的立体选择性偶联反应中的应用
J Am Chem Soc. 2024 Oct 16;146(41):28427-28436. doi: 10.1021/jacs.4c09983. Epub 2024 Oct 2.
6
Synthetic pathways to create asymmetric center at C1 position of 1-substituted-tetrahydro-β-carbolines - a review.在1-取代-四氢-β-咔啉的C1位创建不对称中心的合成途径——综述
RSC Adv. 2024 Sep 19;14(41):29827-29847. doi: 10.1039/d4ra05961a. eCollection 2024 Sep 18.
7
Synthesis of Spiropyrrolines One-Pot TfO-Mediated Amide Activation/Formal [3 + 2]-Cycloaddition of α-Formylamino Ketones.螺吡咯啉的合成:三氟甲磺酸根介导的酰胺活化/α-甲酰氨基酮的形式[3+2]环加成一锅法
J Org Chem. 2024 Sep 20;89(18):13031-13037. doi: 10.1021/acs.joc.4c01128. Epub 2024 Sep 4.
8
Organocatalytic diastereo- and atropo-selective construction of eight-membered bridged (hetero)biaryls asymmetric intramolecular [3 + 2] cycloaddition.有机催化的八元桥连(杂)联芳基的非对映和轴手性选择性构建:不对称分子内[3 + 2]环加成反应
Chem Sci. 2024 May 7;15(23):8880-8887. doi: 10.1039/d4sc01892c. eCollection 2024 Jun 12.
9
Synthesis of Complex Tetracyclic Fused Scaffolds Enabled by (3 + 2) Cycloaddition.通过(3 + 2)环加成实现复杂四环稠合骨架的合成
Org Lett. 2024 Jun 14;26(23):4873-4876. doi: 10.1021/acs.orglett.4c01269. Epub 2024 May 31.
10
Decarboxylative 1,3-dipolar cycloadditions of l-proline.L-脯氨酸的脱羧1,3-偶极环加成反应
RSC Adv. 2024 Mar 13;14(12):8481-8501. doi: 10.1039/d3ra08160e. eCollection 2024 Mar 6.
通过催化对映选择性合成灵感来自于裂环环烯醚萜的化合物库来发现 Wnt 和 Hedgehog 信号通路的抑制剂。
Angew Chem Int Ed Engl. 2013 Nov 18;52(47):12404-8. doi: 10.1002/anie.201306948. Epub 2013 Oct 2.
4
Enantioselective copper-catalyzed [3+3] cycloaddition of azomethine ylides with azomethine imines.铜催化的甲亚胺叶立德与甲亚胺亚胺的对映选择性[3+3]环加成反应
Angew Chem Int Ed Engl. 2013 Nov 25;52(48):12641-5. doi: 10.1002/anie.201307317. Epub 2013 Oct 2.
5
Catalytic asymmetric exo-selective [6+3] cycloaddition of iminoesters with fulvenes.亚胺酯与富烯的催化不对称外消旋[6+3]环加成反应。
Chem Commun (Camb). 2013 Sep 14;49(71):7800-2. doi: 10.1039/c3cc43824d.
6
Discovery of neuritogenic compound classes inspired by natural products.受天然产物启发发现神经突生成化合物类别。
Angew Chem Int Ed Engl. 2013 Sep 2;52(36):9576-81. doi: 10.1002/anie.201302045. Epub 2013 Jun 3.
7
Silver-catalyzed enantioselective desymmetrization: facile access to spirolactone-pyrrolidines containing a spiro quaternary stereogenic center.银催化的对映选择性去对称化:易于获得含有螺旋季立体中心的螺内酯-吡咯烷。
Org Lett. 2013 May 3;15(9):2250-3. doi: 10.1021/ol400821q. Epub 2013 Apr 23.
8
Highly enantioselective catalytic synthesis of neurite growth-promoting secoyohimbanes.促进神经突生长的异育亨烷类化合物的高对映选择性催化合成。
Chem Biol. 2013 Apr 18;20(4):500-9. doi: 10.1016/j.chembiol.2013.03.011.
9
Catalytic Asymmetric Synthesis of Highly Substituted Pyrrolizidines.高度取代吡咯里西啶的催化不对称合成
Chem Sci. 2012 Nov 13;4(2):650-654. doi: 10.1039/C2SC21617E.
10
Fulvenes as effective dipolarophiles in copper(I)-catalyzed [6+3] cycloaddition of azomethine ylides: asymmetric construction of piperidine derivatives.富烯作为铜(I)催化的甲亚胺叶立德[6+3]环加成反应中的有效亲偶极体:哌啶衍生物的不对称构建
Angew Chem Int Ed Engl. 2013 Mar 4;52(10):2934-8. doi: 10.1002/anie.201208799. Epub 2013 Jan 30.